Keyphrases
Social Withdrawal
73%
Biological Measures
48%
Cognitive Deficits
48%
Social Deficits
48%
Early Symptoms
40%
Alzheimer's Disease
40%
Schizophrenia
40%
Major Depressive Disorder
36%
Neuropsychiatric Diseases
32%
Visible Burrow System
24%
Psychiatry
24%
Mouse Strain
24%
New Intervention
24%
Pharmaceutical Companies
24%
Behavioral Paradigms
24%
Pharmacogenetics
24%
Innovative Medicines Initiative
24%
Public-private Cooperation
24%
Biological Approach
24%
Academic Major
24%
Academic Center
24%
Social Brain Hypothesis
24%
Darwinian Paradox
24%
C57BL
24%
Sensing Circuit
24%
Sociability
24%
Psychiatric Disorders
16%
Blood Test
12%
Common Disease
12%
Biological Parameters
12%
Brain Scans
12%
Biological Rationale
12%
Clinical Symptoms
12%
Mental Illness
12%
Circuit Development
12%
Neural Circuit Development
12%
Neurodevelopmental Trajectory
12%
Neurological Disorders
12%
Sensory Processing Deficits
12%
Brain Measures
12%
Being Digital
8%
Antipsychotics
8%
Sertraline
8%
Personalized Medicine
8%
Personal Recovery
8%
Rodents
8%
First International
8%
Dropout
8%
Risperidone
8%
Digital Phenotyping
8%
Pharmacological Treatment
8%
Metabolizer Status
8%
Clinical Effect
8%
Randomized Controlled Trial
8%
Psychotic Disorders
8%
Trial-and-error
8%
Anxiety Disorders
8%
Recovery Assessment Scale
8%
Long-term Processes
8%
Escitalopram
8%
Pharmacotherapy
8%
Antidepressants
8%
Randomized Controlled Study
8%
Patient's Will
8%
Dose Adjustment
8%
Psychosocial Functioning
8%
General Well-being
8%
Dosing Guidelines
8%
Symptomatic Remission
8%
Cytochrome P450 2D6 (CYP2D6)
8%
Treatment Failure
8%
Aripiprazole
8%
CYP2C19
8%
Dosing Recommendations
8%
Guided Therapy
8%
Mood Disorders
8%
BTBR Mice
8%
Cognitively Normal Older Adults
5%
Neuroscience
Alzheimer's Disease
100%
Dementia Praecox
85%
Cognitive Disorders
56%
Psychiatry
53%
Social Behavior
52%
Major Depressive Disorder
48%
Behavior (Neuroscience)
41%
Pervasive Developmental Disorder
29%
Genetic Variation
24%
Treatment Development
24%
Neuropsychiatry
24%
Sensory Processing
24%
Neurological Disorder
24%
Subjective Cognitive Decline
19%
Schizophrenia Spectrum Disorder
17%
Typical Antipsychotic
12%
Synaptic Plasticity
12%
Escitalopram
12%
Brain Plasticity
12%
Risperidone
12%
Prefrontal Cortex
12%
Mood Disorder
12%
Sertraline
12%
Neuroscience
12%
Gene Mutation
12%
Glutamic Acid
12%
Randomized Controlled Trial
12%
Neural Circuit
12%
Cytochrome P450 2D6
12%
Gamma-Aminobutyric Acid
12%
Cytochrome P450 2C19
12%
Amygdala
12%
Aripiprazole
12%
Depression
12%
Psychosis
12%
Anxiety Disorder
12%
Antidepressant
12%
Social Interaction
9%
Negative Syndrome
8%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
36%
Cognitive Defect
36%
Major Depression
36%
Clinical Study
24%
Disease
24%
Pharmacogenetics
24%
Symptom
24%
Side Effect
16%
Drug Development
12%
Clinical Research
12%
Disease Classification
12%
Risperidone
8%
Typical Antipsychotic
8%
Sertraline
8%
Randomized Controlled Trial
8%
Remission
8%
Aripiprazole
8%
Pharmacotherapy
8%
Escitalopram
8%
CYP2D6
8%
Anxiety Disorder
8%
Mood Disorder
8%
Psychosis
8%
Antidepressant
8%
CYP2C19
8%